Selective decrease in axonal nerve growth factor and insulin-like growth factor I immunoreactivity in axonopathies of...

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• Axonopathies of unknown origin present diagnostic challenges.
• Previous studies identified decreased neurofilaments and increased beta tubulin in these conditions.
• Understanding the role of growth factors is crucial for elucidating disease mechanisms.

Purpose of the Study:

• To investigate the expression of growth factors and their receptors in idiopathic axonopathies.
• To correlate growth factor levels with axonal cytoskeleton changes and regeneration failure.
• To differentiate these neuropathies from other conditions like chronic inflammatory demyelinating neuropathy.

Main Methods:

• Immunocytochemistry was used to analyze growth-associated protein 43 (GAP-43), neurotrophin-3 (NT-3), nerve growth factor (NGF), and insulin-like growth factor I (IGF-I).
• Previous morphometric analysis of neurofilaments and beta tubulin was considered.
• Comparison with control cases and chronic inflammatory demyelinating neuropathy cases was performed.

Main Results:

• GAP-43 immunolabeling was not upregulated, contrasting with beta tubulin and correlating with failed regeneration.
• Neurotrophin-3 (NT-3) and its receptor TrkC levels remained unchanged compared to controls.
• A significant decrease (approximately 50%) in NGF and IGF-I positive fibers was observed, independent of fiber density loss.

Conclusions:

• Reduced NGF and IGF-I supply from neuronal targets may contribute to idiopathic axonopathies.
• The observed changes in growth factors are distinct from those in experimental diabetic neuropathy and chronic inflammatory demyelinating neuropathy.
• These findings suggest a potential mechanism involving deficient growth factor signaling in the pathogenesis of these axonal disorders.